In a hearing on March 24 in the Zofran Products Liability MDL, counsel for defendant GlaxoSmithKline asked U.S. District Judge F. Dennis Saylor IV to grants its motion for summary judgment, arguing that the plaintiffs’ own expert failed to make a link between the drug...
U.S. District Judge F. Dennis Saylor IV, who is handling the first bellwether in the MDL that relates to Zofran, has announced the date of October 18th as the potential start of the trial. Plaintiffs allege that Zofran, a drug manufactured by GlaxoSmithKline to ease...
On January 29, the judge presiding over the Valsartan litigation, US District Judge Robert B. Kugler refused to dismiss claims of fraud brought by the consumers against the defendant manufacturers in three master complaints; similar claims against wholesalers and...
Women make up a majority of the group of 25 attorneys appointed by a New Jersey federal judge on January 22 to the Elmiron MDL leadership team; the team also includes a significant number of minority women and younger attorneys who have never served in leadership...
Clearview Al, a facial recognition technology company, is facing a series of lawsuits. Plaintiffs claim that the company was “scraping together” facial data from various social media platforms such as Facebook, Instagram and Twitter and selling access to a compiled...
Consumers in the Elmiron MDL against Johnson & Johnson (J&J) informed a New Jersey federal judge that they have chosen diverse representation to serve on the plaintiff steering committee. The committee is diverse in a number of ways, including ethnicity,...
There have been a number of groups affected by the pending MDL involving Zantac, the popular heartburn medication. It is alleged that the defendants knew that Zantac was hazardous to consumers for years, but it only became publicly known in September, 2019 when the...
On Tuesday, December 15th the JPML sent all Elmiron cases to be tried in New Jersey by U.S. Judge Brian R. Martinotti. The judge had been handling Elmiron lawsuits and had already set up processes resembling those typically followed in MDLs. Because those efforts were...
At the last JPML hearing held on Thursday, December 4th, the panel heard from counsel for Johnson & Johnson and lawyers for plaintiffs. Both sides presented arguments for creating an MDL for all Elmiron cases in New Jersey federal court. Those proposing NJ as...
The FDA has notified Novartis that it has rejected their request to add a birth defect warning to Zofran’s label. Plaintiffs claim that Zofran, a drug used to treat nausea for cancer and surgery patients, was also promoted by GlaxoSmithKline - the original developer...
